Prognostic importance of some clinical and therapeutic factors for the effect of portal vein embolization in patients with primarily inoperable colorectal liver metastases

Archives of Medical Science

Volumn 9, Issue 1, 2013, Pages 47-54

  Treska, Vladislav ^a   Skalicky, Tomas ^a   Sutnar, Alan ^a   Vaclav, Liska ^a   Fichtl, Jakub ^a   Kinkorova, Judita ^b   Vachtova, Monika ^a   Narsanska, Andrea ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

Colorectal liver metastases; Portal vein embolization; Prognostic factors

Indexed keywords

INDOCYANINE GREEN;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; COLORECTAL LIVER METASTASIS; FEMALE; HUMAN; LIVER HYPERTROPHY; LIVER METASTASIS; LIVER PARENCHYMA; LIVER RESECTION; LIVER WEIGHT; MALE; PORTAL VEIN; TUMOR GROWTH;

EID: 84874909227     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2013.33348     Document Type: Article

References (40)

1. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Haw - kins WG, Strasberg SM. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 2005; 200: 845-53.
2. Ellis LM, Curley SA, Grothey A. Surgical resection after down-sizing of colorectal liver metastasis in era of bevacizumab. J Clin Oncol 2005; 23: 4853-5.
3. Barbaro B, Di SC, Nuzo G. Preoperative right portal vein embolization in patients with metastatic liver disease: metastatic liver volumes after RPVE. Acta Radiol 2003; 44: 98-102.
4. Brozek W, Bises G, Girsch T. Differentiation-dependent espression and mitogenic action of interleukin-6 in human colon carcinoma cells: relevance for tumour progression. Eur J Cancer 2005; 41: 2347-54.
5. De Graaf W, van den Esschert JW, van Lienden KP, van Gulik TM. Induction of tumor growth after preoperative portal vein embolization: is it a real problem? Ann Surg Oncol 2009; 16: 423-30.
6. Park SH, Sung JY, Han SH, et al. Oxaliplatin, folinic acid and 5-fluorouracil (FOLFOX-4) combination chemotherapy as second-line treatment in advanced colorectal cancer patients with irinotecan failure: a Korean single-center experience. Jpn J Clin Oncol 2005; 35: 531-5.
7. Emmanoulides C, Sfakiotaki G, Androulakis N, et al. Frontline bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study. BMC Cancer 2007; 7: 91-8.
8. Ryska M, Pantoflicek J, Dusek L. Surgery for liver metastases of colorectal etiology in Czech Republic-Current National Survey. Rozhl Chir 2010; 89: 100-8.
9. Shimada H, Tanaka K, Endou I, Ichikawa Y. Treatment for colorectal liver metastases: a review. Langenbecks Arch Surg 2009; 394: 973-83.
10. Gilson N, Honoré C, De Roover A, et al. Surgical management of hepatic metastases of colorectal origin. Acta Gastroenterol Belg 2009; 72: 321-6.
11. Treska V, Skalicky T, Sutnar A, Liska V. The surgical treatment of colorectal liver metastases. Rozhl Chir 2009; 88: 69-75.
12. Neumann UP, Seehofer D, Neuhaus P. The surgical treatment of hepatic metastases in colorectal carcinoma. Dtsch Arztbl Int 2010; 107: 335-42.
13. Farges O, Belghiti J, Kianmanesh R. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2003; 237: 208-17.
14. Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyeer EM, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on regeneration. Br J Surg 2007; 94: 1386-94.
15. Liu H, Zhu S. Present status and future perspectives of preoperative portal vein embolization. Am J Surg 2009; 197: 686-90.
16. Gulik T, Esschert JW, Graaf W, et al. Controversies in the use of portal vein embolization. Dig Surg 2008; 25: 436-44.
17. Kokudo N, Tada K, Seki M. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 2001; 34: 267-72.
18. Hemming AW, Reed AI, Howard RJ. Preoperative portal vein embolization for extended hepatectomy. Ann Surg 2003; 237: 686-91.
19. Yokoyama Y, Nagino M, Nimura Y. Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J Surg 2007; 31: 367-74.
20. Aussilhou B, Lesurtel M, Sauvanet A. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg 2008; 12: 297-303.
21. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartzm RE, Keene CD, Ortiz-Gonzales XR. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-9.
22. Furst G, Schulte EJ, Hosch SB. Portal vein embolization and autologous CD 133+ bone marrow stem cells for liver regeneration: initial experience. Radiology 2007; 234: 171-9.
23. Komori K, Nagino M, Nimura Y. Hepatocyte morphology and kinetics after portal vein embolization. Br J Surg 2006; 93: 745-51.
24. Furrer K, Tian Y, Pfammatter T, et al. Selective portal vein embolization and ligation trigger different regenerative responses in the rat liver. Hepatology 2008; 47: 1615-23.
25. Kokudo N, Tada K, Seki M, et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 2001; 34: 267-72.
26. Ogata S, Belghiti J, Farges O, Varma D, Silbert A, Vilgrain V. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg 2006; 93: 1091-8.
27. Hayashi H, Beppu T, Sugita H, et al. Serum HGF and TGFbeta1 levels after right portal vein embolization. Hepatology Res 2010; 40: 311-7.
28. Selzner N, Pestalozzi BC, Kadry Z, Selzner M, Wildermuth S, Clavien PA. Downstaging colorectal liver metastases by concomitant unilateral portal vein ligation and selective intraarterial chemotherapy. Br J Surg 2004; 93: 587-92.
29. Hayashi S, Baba Y, Ueno K. Acceleration of primary liver tumor growth rate in an embolized hepatic lobe after portal vein embolization. Acta Radiol 2007; 48: 721-7.
30. Jaeck D, Bachellier P, Nakano H. One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg 2003; 185: 221-9.
31. Beal IK, Anthony S, Papadopoulou A. Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy. Br J Radiol 2006; 79: 473-8.
32. Goere D, Farges O, Leporrier J. Chemotherapy does not impact hypertrophy of the left liver after right portal vein obstruction. J Gastrointest Surg 2006; 10: 365-70.
33. Tanaka K, Kumamoto T, Matsuyama R, Takeda K, Nagano Y, Endo I. Influence of chemotherapy on liver regeneration induced by portal vein embolization or first hepatectomy of a staged procedure for colorectal liver metastases. J Gastrointest Surg 2010; 14: 359-68.
34. Fehér J, Németh E, Lengyel G. Non-alcoholic steatohepatitis (NASH). Arch Med Sci 2005; 1: 37-47.
35. Treska V, Skalicky T, Sutnar A, et al. Portal vein branch embolization in patients with primary inoperable liver tumors. Rozhl Chir 2010; 9: 456-60.
36. Boxberger F, Albrecht H, Konturek P, et al. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24hinfusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial. Med Sci Monit 2010; 16: CR 49-55.
37. Stec R, Grala B, Maczewski M, Bodnar L, Zegadlo A, Szczylik C. Combination of monoclonal antibody (Bevacizumab) and chemotherapy (FOLFIRI) in paliative treatment of metastatic adenocarcinoma of the small bowel (SBC): case report and review of the literature. Arch Med Sci 2009; 5: 647-51.
38. Belghiti J, Benhaim L. Portal vein occlusion prior to extensity resection in colorectal liver metastasis: a necessity rather than an option. Ann Surg Oncol 2009; 16: 1098-9.
39. Wicherts DA, de Haas RJ, Andreani P, et al. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg 2010; 97: 240-50.
40. Jaeck D, Oussoultzoglou E, Rosso E. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004; 240: 1037-49.